Join us Dec. 1-3 in New Orleans for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
After early success, the NFL plans more creator-led broadcasts
After tapping four creators to host alternative broadcasts on YouTube of this season’s opening game, the league is already figuring out who’s next,
How AI is reinventing the holiday gift guide
Beyond driving immediate sales, brands this year are angling to get into gift guides to help them with SEO and GEO.
In Graphic Detail: The rise of micro dramas that are attracting big ad dollars
Micro dramas are attracting attention, so Digiday has charted the format’s revenue forecasts and viewership, to understand how we got here.